Annual Report 2022

CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME For the year ended 31 December 2022 43 The United Laboratories International Holdings Limited Annual Report 2022 2022 2021 NOTES RMB’000 RMB’000 Revenue 5 11,334,262 9,703,438 Cost of sales (6,365,272) (5,492,391) Gross profit 4,968,990 4,211,047 Other income 6 165,817 155,879 Other gains and losses, net 7a (88,571) 19,256 Selling and distribution expenses (1,662,435) (1,633,456) Administrative expenses (703,354) (698,335) Other expenses 7b (603,615) (494,954) Impairment losses reversed (recognised) under expected credit loss model, net 9 11,718 (296,559) Share of results of an associate 21 (189) – Finance costs 8 (81,595) (60,231) Profit before taxation 2,006,766 1,202,647 Tax expense 11 (425,743) (213,062) Profit for the year 12 1,581,023 989,585 Other comprehensive income Item that may be reclassified subsequently to profit or loss: Exchange differences arising on translation of foreign operations 1,427 475 Total comprehensive income for the year 1,582,450 990,060